Bahl & Gaynor’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-14,948
Closed -$405K 408
2016
Q1
$405K Buy
14,948
+614
+4% +$16.4K 0.01% 331
2015
Q4
$416K Sell
14,334
-10,320
-42% -$286K 0.01% 336
2015
Q3
$669K Buy
24,654
+194
+0.8% +$5.49K 0.01% 276
2015
Q2
$670K Sell
24,460
-500
-2% -$14.1K 0.01% 287
2015
Q1
$666K Hold
24,960
0.01% 273
2014
Q4
$528K Sell
24,960
-200
-0.8% -$4.47K 0.01% 287
2014
Q3
$599K Sell
25,160
-1,600
-6% -$36.8K 0.01% 263
2014
Q2
$618K Hold
26,760
0.01% 252
2014
Q1
$611K Sell
26,760
-1,840
-6% -$39.2K 0.01% 250
2013
Q4
$528K Sell
28,600
-300
-1% -$5.23K 0.01% 259
2013
Q3
$489K Hold
28,900
0.01% 249
2013
Q2
$448K Buy
+28,900
New +$481K 0.01% 244

Other funds holding NVO